^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5%, Ringer’s injection, lactated, sodium chloride 0.45%, and sodium chloride 0.9%.

^e Tested in sodium chloride 0.45%.

^f Tested in dextrose 5% with albumin human 2 mg/mL.

^g Tested in sterile water for injection.

^h Lyophilized formulation tested.

ⁱ Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^j A 32.5-mL sample of parenteral nutrition solution mixed with 50 mL of antibiotic solution.

^k Run at 21 mL/hr.

^l Given over 30 minutes by syringe pump.

^m Run at 94 mL/hr.

ⁿ Run at 10 mL/hr.

^o Given over one hour by syringe pump.

^p Injected via Y-site into an administration set running azithromycin.

^q Tested in Ringer’s injection, lactated.

^r Final concentration after mixing.

^s Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

^t Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

^u Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^v Tested in dextrose 5% in sodium chloride 0.45%.

^w Test performed using the formulation WITHOUT edetate disodium.

^x Test performed using the formulation WITH edetate disodium.

^y Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^z Tested as the premixed infusion solution.

^aa Salt not specified.

^bb Quinupristin and dalfopristin components combined.

^cc Test performed using the Cubicin formulation.

^dd Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^ee Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^ff Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^gg Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^hh Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

ⁱⁱ Run at 100 mL/hr.

^jj Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^kk Intralipid product.

^ll SMOFlipid product.